Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SLx-4090 in subjects with high triglycerides
NCT00562575Phase 2Completed
- Sponsor
- Response Pharmaceuticals
- Start
- May 2007
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of KD026 in hypertriglyceridemia, sponsored by Response Pharmaceuticals. Started May 2007; status: completed.
02
Drugs
KD026
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT00562575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00562575.